BRIEF-Azurrx Biopharma agrees in principle with Transchem for MTAN inhibition technology
* Azurrx Biopharma announces agreement in principle with transchem for MTAN inhibition technology Source text for Eikon: Further company coverage:
GREATER NOIDA, India Feb 5 France's Renault may launch a car priced below 450,000 rupees ($7,200) in India, a senior executive said on Monday, as the company looks to tap the biggest and fastest growing segment of the Indian car market.
"Half of the market we are not addressing. What is happening below 450,000 rupees, we don't have any cars so that's a big space," Marc Nassif, head of Renault's India operations told Reuters at the Indian auto show.
"Obviously, we want to go there," he said, without giving details of the possible launch in that segment.
The company also plans to increase its dealership network in the country to 175 by the end of this year up from 125 at end December 2013, he said.
* America First Multifamily Investors LP receives proceeds of $7 million from issuance of series a preferred units
* Asure Software Inc announces pricing of public offering of common stock